Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in the United States, Symphony Alpha Ventures is a venture capital firm dedicated to investing in early-stage healthcare technology companies. Established with a mission to support promising startups in the healthcare IT sector, the firm leverages its affiliation with Symphony Corporation to enhance the development and commercialization of innovative healthcare solutions. Symphony Alpha Ventures primarily targets companies that demonstrate strong entrepreneurial teams and the potential for recurring revenues through Software as a Service (SaaS) models. The firm has successfully facilitated multiple exits, showcasing its ability to identify and nurture high-potential startups. With a focus on pre-seed, seed, and seed-plus investment stages, Symphony Alpha Ventures has built a reputation for its strategic approach to healthcare technology investments.
Symphony Alpha Ventures specializes in early-stage investments in healthcare technology companies, particularly those that utilize innovative technologies to improve workflow and healthcare delivery. The firm seeks to partner with startups that have developed a minimum viable product (MVP) and are focused on SaaS models leveraging cloud-based technologies. Their investment strategy encompasses not only capital investment but also product development support and strategic partnerships. This comprehensive approach aims to help companies refine their business models and accelerate their market penetration. By focusing on the healthcare sector, Symphony Alpha Ventures is committed to enhancing patient care and operational efficiency through technology-driven solutions.
Symphony Alpha Ventures boasts a strong portfolio with notable exits that highlight its successful investment strategy in the healthcare technology sector. Key exits include **Starchup**, acquired by Cents in August 2022; **ReviewTrackers**, acquired by InMoment in June 2022; and **Hitch Works**, acquired by ServiceNow in June 2022. Other significant exits include **Explorer Surgical**, acquired by Global Healthcare Exchange in October 2021; **GrocerKey**, acquired by Point Pickup in August 2021; **Encube.ai**, acquired by Hitch Works Inc. in August 2021; and **Falcon Care**, acquired by MD Revolution in November 2019. Additionally, the firm developed the **SymphonyCare** technology platform, which was acquired by Influence Health, and contributed to products for **Liazon Corporation**, which was acquired for $215 million, and **Symphony Data Corporation**. These successful exits underscore the firm's ability to identify and support high-potential healthcare startups.
Symphony Alpha Ventures invests in pre-seed, seed, and seed-plus stages, focusing on early-stage healthcare technology companies.
To pitch Symphony Alpha Ventures, founders should prepare a detailed presentation that outlines their business model, market potential, and technology. A minimum viable product (MVP) is preferred.
The firm primarily focuses on the healthcare sector, particularly healthcare technology companies that utilize SaaS models and innovative technologies to enhance workflow and improve healthcare delivery.
While specific check sizes are not disclosed, Symphony Alpha Ventures typically invests in early-stage companies, which may range from seed funding to larger seed-plus investments.
Symphony Alpha Ventures is based in the United States and primarily invests in U.S.-based healthcare technology startups.
The firm offers product development support and strategic partnerships to help portfolio companies refine their business models and accelerate market penetration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.